63.28USD-12.80%Mkt Cap: 2.71B USDP/E: —Last update: 2026-06-01
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individ…
Industry Peers
Diagnostics & Research183.26BUSDP/E 27.1
127.46BUSDP/E 35.0
45.09BUSDP/E 42.1
38.48BUSDP/E 27.4
37.00BUSDP/E 47.9
34.66BCHFP/E 38.1
31.51BUSD—
31.45BUSDP/E 23.4
Indicators:|
Key Statistics
Company
Market Cap2.71B USD
Enterprise Value2.30B USD
Revenue (TTM)156.12M USD
Gross Profit-62.57M USD
Net Income (TTM)-408.35M USD
Revenue/Share4.072 USD
Last Price63.28 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees910
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.81
PEG—
EV/EBITDA-6.39
EV/Revenue14.76
P/S19.70
P/B1.18
EPS (TTM)-10.30
EPS (Forward)-9.18
52W Range
29.9538% of range118.84
52W High118.84 USD
52W Low29.95 USD
Profitability
Gross Margin-42.52%
Oper. Margin-332.88%
EBITDA Margin-230.91%
Profit Margin-277.47%
ROE-15.84%
ROA-13.97%
Growth
Revenue Growth28.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-299.01M USD
CapEx (TTM)909.00K USD
FCF Margin-69.02%
FCF Yield-3.98%
Net Debt-772.08M USD
Net Debt/EBITDA2.14
Balance Sheet
Debt/Equity0.02
Current Ratio11.74
Quick Ratio11.29
Book Value/Sh60.79 USD
Cash/Share19.18 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)66.86 USD
Target Range56.00 USD – 80.00 USD
# Analysts7
Ownership
Shares Out.42.92M
Float33.69M
Insiders4.72%
Institutions83.58%
Short Interest
Short Ratio12.3d
Short % Float16.94%
Short % Out.16.66%
Shares Short7.15M
Short (prev mo.)6.99M
Technical
SMA 5055.22 (+14.6%)
SMA 20069.30 (-8.7%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)611.69K
Avg Vol (10d)662.17K
Technical Indicators
RSI (14)68.1
MACD4.5944
MACD Signal3.5066
MACD Hist.+1.0878
BB Upper75.06 USD
BB Middle63.41 USD
BB Lower51.77 USD
BB Width36.74%
ATR (14)4.196 USD
Vol Ratio (20d)0.94x